NCT04387305View on ClinicalTrials.gov

Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: an Efficacy Study

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

March 31, 2030

Study Completion Date

March 31, 2030

Conditions
Brain Injuries, TraumaticWounds and InjuryHemorrhageTrauma Injury
Interventions
DRUG

Tranexamic acid injection

Active drug is provided to participants as described based on the TXA arm they are randomized to.

All Listed Sponsors
collaborator

Pediatric Emergency Care Applied Research Network

NETWORK

lead

Daniel Nishijima, MD, MAS

OTHER